May 19, 2014
Dear Nelson, I appreciate you so much for your effort in defending HIV and tell us more information about Ibalizumab . On April 24 you talked about Ibalizumab and you wrote that we hopefully will hear something by June.Do you have any new good news about it now?
Response from Mr. Vergel
We are still waiting about the FDA review of the drug for orphan drug status. It may happen soon, I hope.
Orphan drug status will make it easier for the IV administration to get approved for patients with limited HIV treatment options.
Are you waiting to access ibalizumab?
I am also following two new drugs closely made by BMS. They have an attachment and a maturation inhibitor that will start their phase 3 studies early next year. Both drugs could work in deep salvage patients.
Check back with me in a month or so to keep you updated. What is your current situation?
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.